HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathwaysRan Duan(Capital Medical University), Lei Wang(Beijing Tian Tan Hospital)OncotargetJuly 31, 201510.18632/oncotarget.4813Cited by 105SaveCiteExport RISWatch citationsRelated PapersPIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup|PLoS ONE|2014|162Oxidized phospholipids are ligands for LRP6|Bone Research|2018|43